An open label randomised controlled trial on inhaled remdesivir for COVID-19 (SARS-CoV-2) infection
Grant Data
Project Title
An open label randomised controlled trial on inhaled remdesivir for COVID-19 (SARS-CoV-2) infection
Principal Investigator
Professor Hung, Fan Ngai Ivan
(Principal Investigator (PI))
Co-Investigator(s)
Dr Chan Kwok Hung
(Co-principal investigator)
Professor Yuen Kwok Yung
(Co-principal investigator)
Professor To Kelvin Kai Wang
(Co-principal investigator)
Duration
24
Start Date
2023-09-01
Amount
1499200
Conference Title
An open label randomised controlled trial on inhaled remdesivir for COVID-19 (SARS-CoV-2) infection
Keywords
Open-label, randomized, trial, inhaled, remdesivir
Discipline
Others - Medicine, Dentistry and Health
Panel
Biology and Medicine (M)
HKU Project Code
22210952
Grant Type
Health and Medical Research Fund 2021
Funding Year
2023
Status
On-going
Objectives
To evaluate the safety and efficacy in clinical improvement and viral load reduction with a 3-day inhaled remdesivir in the treatment of patient hospitalised for SARS CoV-2 infection comparing to oral molnupiravir treatment